Definium Therapeutics, Inc. (DFTX)
23.48
-0.04
(-0.15%)
USD |
NASDAQ |
May 28, 16:00
23.45
-0.04
(-0.15%)
After-Hours: 19:05
Definium Therapeutics Total Liabilities (Quarterly) : 122.44M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Atai Beckley, Inc. | 66.10M |
| Resonate Blends, Inc. | 6.097M |
| Nutriband, Inc. | 0.8684M |
| Q/C Technologies, Inc. | 14.60M |
| GH Research Plc | 11.89M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 401.29M |
| Shareholders Equity (Quarterly) | 278.85M |
| Debt to Equity Ratio | 0.1462 |
| Current Ratio | 4.692 |
| Net Debt Paydown Yield | -0.19% |